Viewing Study NCT04762628


Ignite Creation Date: 2025-12-26 @ 10:34 AM
Ignite Modification Date: 2026-03-09 @ 11:22 AM
Study NCT ID: NCT04762628
Status: COMPLETED
Last Update Posted: 2023-02-27
First Post: 2021-02-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Trial Efficacy of Saisei Pharma Dietary Supplements MAF Capsules, 148 mg and M Capsules, 148 mg in Hospitalized COVID-19 Patients
Sponsor: Saisei Pharma
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Covid19 View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Oxygen supply View
None Covid19 View
None Colostrum MAF View
None Supplements View
None Mortality View
None Clinical improvement View
None lymphocyte depletion prevention View